B-CELL ALL
Clinical trials for B-CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B-CELL ALL trials appear
Sign up with your email to follow new studies for B-CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B-CELL ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Donor cells Re-Engineered to hunt down relapsed blood cancers
Disease control OngoingThis early-phase study is testing the safety of a new cell therapy for patients whose blood cancer (like leukemia or lymphoma) has come back after a stem cell transplant from a donor. Doctors take immune cells (T cells) from the donor, genetically modify them in a lab to better r…
Matched conditions: B-CELL ALL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC